WILMINGTON, Del., Jan. 15, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Dermira, Inc. (NASDAQ GS: DERM) regarding possible breaches of fiduciary.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum! Brands, Inc. Under the terms of the acquisition agreement, HABT shareholders will receive $14.00 in cash for each HABT share they own.

NEW YORK, Jan. 29, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: The Habit Restaurants, Inc. (NASDAQ: HABT)The.

Eli Lilly's (LLY) Q4 earnings and sales beat estimates. Shares rise in pre-market trading.

NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Hexcel Corporation (NYSE:HXL) The investigation concerns ...

WILMINGTON, Del., Feb. 04, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: CenterState Bank Corporation (NASDAQ GS: CSFL) regarding possible breaches of.

Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Dermira, Inc. (NASDAQ: DERM), Primo Water Corporation (NASDAQ: PRMW), Hexcel Corporation (NYSE: HXL), and Pope Resources, A Delaware Partnership (NASDAQ: POPE). Additional information about each potential action can be found at the link provided.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cincinnati Bell Inc. (CBB) in connection with the proposed acquisition of the Company by Brookfield Infrastructure Partners L.P.  Under the terms of the acquisition agreement, CBB shareholders will receive $10.50 in cash for each CBB share that they own. Weiss Law LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum!

Q3 2019 Dermira Inc Earnings Call

Gurus loaded up on Enterprise Products Partners, dumped Trinet Group Continue reading...

The drugmaker has been expanding its treatment portfolio and boosting sales of its newer drugs as older medicines including erectile dysfunction treatment Cialis lose market share to cheaper copycats. The results also alleviate investors' "exaggerated concerns" over the launch of Novo Nordisk's once-daily oral diabetes pill, Rybelsus, Citi analyst Andrew Baum said. Rybelsus, approved late last year, is expected to be embraced by patients with an aversion to needles used to deliver treatments such as Trulicity.

Eli Lilly and Co aims to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker looks to build up its pipeline of future products. It will focus largely on earlier stage opportunities across key therapeutic areas including oncology, pain, immunology, and neurology, CFO John Smiley told Reuters in an interview at the JP Morgan Healthcare conference in San Francisco earlier this week. Eli Lilly has been on a deal-making spree in recent years in a bid to increase products and sales in core franchises as older blockbuster medicines, such as diabetes treatment Humalog, face generic competition and pressure to lower prices.

NEW YORK, NY / ACCESSWIRE / January 20, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders ...

WILMINGTON, Del., Jan. 28, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Primo Water Corporation (NASDAQ GS: PRMW) regarding possible breaches of.

On January 10, 2020, Dermira announced that it had signed a definitive merger agreement with Lilly. The investigation concerns whether the Dermira board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Dermira shares of common stock.

Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are likely to have performed well. Let's see if these along with older products lead to an earnings beat for the company.

AquaVenture Holdings Limited (WAAS)

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition expands Lilly's immunology pipeline with the addition of lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 with high affinity that is being evaluated in a Phase 3 clinical development program for the treatment of moderate-to-severe atopic dermatitis in adolescent and adult patients, ages 12 years and older. The acquisition of Dermira also expands Lilly's portfolio of marketed dermatology medicines with the addition of QBREXZA® (glycopyrronium), a medicated cloth approved by the FDA for the topical treatment of primary axillary hyperhidrosis (uncontrolled excessive underarm sweating).

NEW YORK, Jan. 20, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cincinnati Bell Inc. (NYSE: CBB) The.

NEW YORK, NY / ACCESSWIRE / February 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: LogMeIn, Inc. (NASDAQ:LOGM) The investigation concerns ...